Identification and characterization of process-related substances and degradation products in apremilast: Process optimization and degradation pathway elucidation

被引:17
作者
Lu, Yuting [1 ]
Shen, Xiaoyue [1 ]
Hang, Taijun [1 ]
Song, Min [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmaceut Anal, Minist Educ, Key Lab Drug Qual Control & Pharmacovigilance, Nanjing 210109, Jiangsu, Peoples R China
关键词
Apremilast; Related substances; LC-MS; Process optimization; PSORIATIC-ARTHRITIS; UPLC-MS/MS; PHOSPHODIESTERASE-4; INHIBITOR; IMPURITIES;
D O I
10.1016/j.jpba.2017.03.067
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This study aims at investigating the separation, identification and characterization of related substances in apremilast by LC-MS hyphenated techniques, as well as the synthesis optimization and the degradation pathways elucidation. Forced degradation studies were conducted under the ICH prescribed stress conditions. The chromatographic separation was achieved on XBridge C18 column (4.6mm x 150mm, 3.5 mu m) using a mobile phase consisting of water adjusted to pH 3.0 with formic acid as solvent A and acetonitrile as solvent B in linear gradient elution program. Twelve related substances were detected all together in apremilast and its stress samples. Their structures were identified mainly through positive ESI high-resolution TOF-MS analysis of the parent ions' accurate masses and elemental compositions, and the corresponding MS/MS spectra elucidation. There were three process-related substances and nine degradation products, seven of them were first reported. Two degradation products and one process related substance were further verified by semi-preparation and NMR determination. Their origins and formation mechanisms were also discussed, based on which effective approaches for the synthesis optimization were conducted. Therefore, the related substances investigation are valuable for apremilast manufacturing process optimization and quality control. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:70 / 78
页数:9
相关论文
共 20 条
  • [1] [Anonymous], 2009, INTERNATIONAL CONFERENCE ON HARMONISATION - ICH Harmonised Tripartite Guideline, Pharmaceutical Development Q8(R2)
  • [2] [Anonymous], 2003, INT C HARMONISATION
  • [3] Fala Loretta, 2015, Am Health Drug Benefits, V8, P105
  • [4] Disposition, metabolism and mass balance of [14C]apremilast following oral administration
    Hoffmann, Matthew
    Kumar, Gondi
    Schafer, Peter
    Cedzik, Dorota
    Capone, Lori
    Fong, Kei-Lai
    Gu, Zheming
    Heller, Dennis
    Feng, Hao
    Surapaneni, Sekhar
    Laskin, Oscar
    Wu, Anfan
    [J]. XENOBIOTICA, 2011, 41 (12) : 1063 - 1075
  • [5] Determination of apremilast in rat plasma by UPLC-MS/MS in ESI-negative mode to avoid adduct ions formation
    Iqbal, Muzaffar
    Ezzeldin, Essam
    Al-Rashood, Sara Ta
    Imam, Faisal
    Al-Rashood, Khalid A.
    [J]. BIOANALYSIS, 2016, 8 (14) : 1499 - 1508
  • [6] Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease
    Kodimuthali, Arumugam
    Jabaris, S. Sugin Lal
    Pal, Manojit
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) : 5471 - 5489
  • [7] The Pharmacokinetic Effect of Coadministration of Apremilast and Methotrexate in Individuals With Rheumatoid Arthritis and Psoriatic Arthritis
    Liu, Yong
    Zhou, Simon
    Nissel, James
    Wu, Anfan
    Lau, Henry
    Palmisano, Maria
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 456 - 465
  • [8] Identification and characterization of related substances in pomalidomide by hyphenated LC-MS techniques
    Lu, Ping
    Wang, Lei
    Song, Min
    Hang, Tai-Jun
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 114 : 159 - 167
  • [9] Discovery of (S)-N-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide (Apremilast), a Potent and Orally Active Phosphodiesterase 4 and Tumor Necrosis Factor-α Inhibitor
    Man, Hon-Wah
    Schafer, Peter
    Wong, Lu Min
    Patterson, Rebecca T.
    Corral, Laura G.
    Raymon, Heather
    Blease, Kate
    Leisten, Jim
    Shirley, Michael A.
    Tang, Yang
    Babusis, Darius M.
    Chen, Roger
    Stirling, Dave
    Muller, George W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) : 1522 - 1524
  • [10] Supramolecular oxidation of anilines using hydrogen peroxide as stoichiometric oxidant
    Marinescu, L
    Molbach, M
    Rousseau, C
    Bols, M
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (50) : 17578 - 17579